← Leaderboards
Jiajiu Shaw
Unitech Pharmaceuticals, Inc
$3,213,583
Attributed
$3,213,583
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $639.5K · FY2006–18$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$3,213,583 · 9
By mechanism
R43$2,079,905 · 8
R44$1,133,678 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Small Business Innovation Research Grant”
- David Heimbrook · Leidos Biomedical Research, Inc.$122,677,088
- Praduman Jain · Vignet, Inc.$106,968,877
- Stephen Lev Hoffman · Sanaria, Inc.$37,771,680
- Eric Baer · Case Western Reserve University$37,136,000
- John B Buse · University Of North Carolina Chapel Hill$23,865,764
- Gary Fanger · Rise Therapeutics, Llc$23,463,293
Research focus
Small Business Innovation Research GrantScale UpPhase 1 StudyTherapeutic EffectIn VivoPhase 2 StudyBaseTumor Necrosis Factor-AlphaDosage FormsSmall MoleculeToxic EffectAnimalsAffectAcuteProductionTechnologyPharmacologic SubstanceInjection Of Therapeutic AgentLiverPre-ClinicalFoundationsHepatotoxicityAdverse EffectsBlood
Grant awards (11)
Development of a Novel Small Molecule as a Radioprotector for Total Body Irradiation$345,914
R43 · FY2018 · HL · contact PI
Development of a Novel ELISA Kit for Screening Potential JAK3 Inhibitors$335,740
R43 · FY2015 · GM · contact PI
Novel Compounds from Sycamore Leaves for the Treatment of MRSA$303,745
R43 · FY2015 · AT · contact PI
Development of a Novel ELISA Kit for Screening Potential JAK3 Inhibitors$338,736
R43 · FY2014 · GM · contact PI
Development of a novel small molecule, UTL-5g, to treat oxaliplatin-induced throm$276,418
R43 · FY2013 · CA · contact PI
Novel small-molecule TNF-a modulators as chemoprotective agents$542,156
R44 · FY2012 · CA · contact PI
Novel small-molecule TNF-a modulators as chemoprotective agents$591,522
R44 · FY2011 · CA · contact PI
Novel Small-molecule TNF-a Modulators as Chemoprotective Agents$154,852
R43 · FY2009 · CA · contact PI
Development of UTL-5b for Rheumatoid Arthritis: Mechanism of Action$100,000
R43 · FY2007 · AR · contact PI
TNF-alpha modulator as a radioprotector in liver$130,000
R43 · FY2006 · CA · contact PI
Feasibility Study of Three NCEs for Rheumatoid Arthritis$94,500
R43 · FY2004 · AR